Uniting Against Lung Cancer (UALC) is dedicated to funding innovative research and raising awareness to find a cure for lung cancer.

Decoding the Research

‘Master Protocol’ is bringing clinical trial design into the 21st century

All new cancer drugs are developed through clinical trials. Clinical trials provide essential information for the FDA and doctors to make informed decisions about whether new drugs are safe and effective. But clinical trials face a number of hurdles including cost, patient...

read more...  June 12th, 2013

Staying fit reduces risk of death from lung and other cancers

New research from the American Society for Clinical Oncology 2013 Annual Meeting: 
Men’s Fitness in Middle Age Protects Against Developing and Dying from Cancer Later in Life

(ASCO) Findings from a large, prospective 20-year study indicate that a high level of cardiovascular...

read more...  May 20th, 2013

Anti-PD-L1 Drug Shows Promising anti-Cancer Effects in a Variety of Advanced Cancers

New research from the American Society for Clinical Oncology 2013 Annual Meeting

(ASCO) A phase I expansion study of the investigational drug MPDL3280A – an engineered PD-L1 targeted antibody – shows impressive tumor shrinkage rates in patients with several different cancers –...

read more...  May 16th, 2013

Signaling networks activated in lung cancer cells yield new drug targets

New published research funded by UALC

Personalized, targeted therapies can offer prolonged survival and fewer side effects for patients whose tumors have specific genetic alterations. However, most patients will eventually become resistant to treatment with targeted drugs....

read more...  May 14th, 2013

Latest Updates
placeholder

New York Mets Step Up to the Plate in the Fight Against Lung Cancer

For the first time ever, the Mets will host a Lung Cancer Awareness Day at Citi Field as part of their ‘Fill the Park for Charity’ series. 

UALC is proud to be the charity partner as the Mets take on the Colorado Rockies on Wednesday, August 7th at 7:10pm.  This initiative...

read more...